Sma News & Perspectives

SMA News Today’s Director of Multichannel Content, Michael Morale, discusses how interim results from a phase 2 trial of Spinraza in infants with SMA support efficacy and safety. Also, Community Development Manager Kevin Schaefer reads from his latest column about sleep and SMA. Are you interested in understanding gene therapy? ExploreGeneTherapy.com has helpful information about gene therapy, including its history and how it is being investigated for the treatment of genetic diseases. Visit www.exploregenetherapy.com